Latest Trials Latest NewsFAQ

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Nutritional Therapy for Diabetic Cardiomyopathy

Completed

Conditions: T2DM (Type 2 Diabetes Mellitus)

First Posted Date: 2011-06-15

Last Posted Date: 2024-01-11

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 22

Registration Number: NCT01373814

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Role of Dopamine Receptors in Primary Focal Dystonias

Completed

Conditions: Focal Dystonias
Healthy

First Posted Date: 2011-06-15

Last Posted Date: 2018-05-15

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 40

Registration Number: NCT01373840

Locations: 🇺🇸
Washington University, Saint Louis, Missouri, United States

Reversal of Obesity Cardiomyopathy

Completed

Conditions: Cardiomyopathy

First Posted Date: 2011-06-13

Last Posted Date: 2024-02-14

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 27

Registration Number: NCT01372397

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer

Phase 2

Terminated

Conditions: Estrogen Receptor-positive Breast Cancer
Stage II Breast Cancer
Stage IIIC Breast Cancer
Stage IIIB Breast Cancer
HER2-negative Breast Cancer
Stage IIIA Breast Cancer

Interventions: Drug: goserelin acetate
Drug: letrozole
Drug: anastrozole
Procedure: Surgery
Drug: chemotherapy

First Posted Date: 2011-06-07

Last Posted Date: 2015-04-03

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 8

Registration Number: NCT01368263

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Comparative Urine Proteomic Studies of Overactive Bladder in Humans

Not Applicable

Completed

Conditions: Overactive Bladder

Interventions: Drug: fesoterodine

First Posted Date: 2011-06-07

Last Posted Date: 2015-02-27

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 21

Registration Number: NCT01367886

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

Reinforced Staple Line on Leak Rate in Distal Pancreatectomy

Not Applicable

Terminated

Conditions: Pancreatic Neoplasms

Interventions: Device: Mesh reinforced staple line (SEAMGUARD)
Device: Stapled without mesh reinforcement (PER-STRIPS DRY)

First Posted Date: 2011-05-24

Last Posted Date: 2017-05-10

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 112

Registration Number: NCT01359410

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

Comparative Effectiveness Multicenter Trial for Adhesion Characteristics of Ventral Hernia Repair Mesh

Completed

Conditions: Adhesions
Ventral Hernia

Interventions: Procedure: Clinically-Indicated Abdominal Re-Exploration Surgery

First Posted Date: 2011-05-19

Last Posted Date: 2015-02-23

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 173

Registration Number: NCT01355939

Locations: 🇺🇸
Washington University, St. Louis, Missouri, United States
🇺🇸
Mayo Clinic Scottsdale, Phoenix, Arizona, United States
🇺🇸
Baystate Medical Center, Springfield, Massachusetts, United States

and more 3 locations

Fat Metabolism in Pregnancy and Neonatal Heart Function in Diabetes

Completed

Conditions: Type 2 Diabetes
Pregnancy

First Posted Date: 2011-05-03

Last Posted Date: 2018-05-11

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 79

Registration Number: NCT01346527

Locations: 🇺🇸
Washington University, Saint Louis, Missouri, United States

BKM120 and Fulvestrant for Treating Postmenopausal Patients With Estrogen Receptor-Positive Stage IV Breast Cancer

Phase 1

Completed

Conditions: Estrogen Receptor-positive Breast Cancer
Recurrent Breast Cancer
Stage IV Breast Cancer

Interventions: Drug: BKM120
Drug: Fulvestrant
Procedure: biopsy

First Posted Date: 2011-04-20

Last Posted Date: 2017-01-25

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 31

Registration Number: NCT01339442

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Ampyra for Optic Neuritis in Multiple Sclerosis

Phase 2

Completed

Conditions: Multiple Sclerosis
Optic Neuritis

Interventions: Drug: Dalfampridine/Placebo
Drug: Placebo/Dalfampridine

First Posted Date: 2011-04-19

Last Posted Date: 2020-01-30

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 53

Registration Number: NCT01337986

Locations: 🇺🇸
Washington University (John L. Trotter MS Center), Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy